Trump administration expands enforcement and Medicaid restrictions on transgender health care, The Hill reports

The Trump administration expanded federal actions aimed at transgender health care this week, The Hill reported, including steps that reduce coverage under Medicaid and referrals that could expose hospitals and clinics to potential prosecution. The moves represent an intensification of enforcement efforts that target how transgender-related services are handled in health programs and clinical settings, according to the report.

Citing the administration’s latest actions, The Hill said the Department of Health and Human Services (HHS) cut Medicaid coverage for some services tied to transgender care. Medicaid is jointly run by the federal government and states, and changes to federal policy can affect which services are reimbursed and how states administer coverage through their state Medicaid plans.

The Hill also reported that the administration referred hospitals and clinics for potential prosecution. The report did not, in the provided summary, specify the identities of the facilities, the statutes at issue, or whether any charges have been filed. It described the referrals as part of a wider effort to increase enforcement around transgender health services.

Administration officials have generally framed such actions as compliance and enforcement within existing federal health-care authorities, and the report characterized the steps as escalation. In practice, enforcement referrals can create new compliance pressure for health systems, affecting clinical policies, documentation, and how billing and patient eligibility decisions are made under Medicaid and other federal programs.

The Medicaid changes and enforcement posture come amid ongoing legal and policy disputes over how federal agencies regulate transgender-related medical care. Because Medicaid is implemented by states, the practical effect of federal restrictions often depends on how quickly states adjust internal guidance, coverage determinations, and provider billing practices.

Providers and advocates have argued in prior disputes that federal restrictions can limit access to medically necessary care and raise concerns about due process and the clarity of applicable requirements. The Hill report’s description of potential prosecution also raised questions about what specific conduct the administration believes triggers criminal exposure, given that criminal referrals can precede any formal action in court.

The report did not provide additional details in its summary about the specific scope of the Medicaid coverage cut, the timing for implementation, or the procedural steps leading from referrals to any charging decisions. The administration’s next steps, including any formal guidance, enforcement communications, or court filings, will determine the timeline of implementation and the legal pathways that test the policy changes.